Minority equity investments by a German pharmaceutical company's innovation fund Grant
organisation
A corporate venture arm based in Germany
In context
This call is open to startups and small and medium-sized businesses. Funding is an equity investment. Coverage is read from the notice itself: any country. The funder accepts early-stage applicants.
A German pharmaceutical company's innovation fund makes minority equity investments in companies pursuing fundamental breakthroughs in healthcare, including genetic diseases, cancer, neuroscience, and immunology. This is a venture capital fund focused on healthcare innovation, not climate or sustainability.
About this grant
Minority equity investments in companies pursuing fundamental breakthroughs across health challenges including genetic disease cures, cancer prevention and cure, cardiometabolic disorders, brain and mind health, autoimmune/chronic inflammation, and women's health. Targets life science teams at various stages.
Unlock the funder, link and full detail
Create a free account to unlock 3 full listings a month, including the funder name, the application link and the complete programme detail.
Frequently asked questions
- Who can apply for Minority equity investments by a German pharmaceutical company's innovation fund?
- Eligibility covers organisations in GLOBAL; startup, sme. The full eligibility conditions are part of the Pro detail.
Free accounts unlock 3 listings a month · Pro unlocks all